Co-Diagnostics, Inc. (CODX) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY, UT 84124 |
| State of Incorp. | UT |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 37,662 | 44,880 | 49,964 | 58,548 | 63,429 | 69,138 | |||
| Cash and cash equivalent | 10,798 | 13,859 | 23,099 | 14,917 | 10,240 | 13,831 | |||
| Short-term investments | 26,865 | 31,021 | 26,864 | 43,632 | 53,189 | 55,307 | |||
| Receivables | 178 | 552 | 435 | 304 | 825 | 1,135 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,266 | 1,464 | 1,550 | 1,665 | 4,520 | 4,691 | |||
| Inventory | 1,266 | 1,464 | 1,550 | 1,665 | 4,520 | 4,691 | |||
| Other undisclosed current assets | 997 | 1,324 | 1,750 | 1,624 | 2,536 | 2,421 | |||
| Total current assets: | 40,103 | 48,219 | 53,699 | 62,141 | 71,311 | 77,385 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 2,333 | 2,547 | 2,759 | 2,967 | 3,032 | 3,229 | |||
| Property, plant and equipment | 2,984 | 3,054 | 3,183 | 3,036 | 2,808 | 2,795 | |||
| Long-term investments and receivables | 784 | 628 | |||||||
| Long-term investments | 784 | 628 | |||||||
| Intangible assets, net (including goodwill) | 26,177 | 26,252 | 26,328 | 26,404 | 26,479 | 26,555 | |||
| Intangible assets, net (excluding goodwill) | 26,177 | 26,252 | 26,328 | 26,404 | 26,479 | 26,555 | |||
| Deferred income tax assets | 4,272 | 2,012 | |||||||
| Other undisclosed noncurrent assets | 702 | 773 | 779 | 825 | |||||
| Total noncurrent assets: | 32,278 | 32,482 | 32,972 | 33,180 | 37,371 | 35,416 | |||
| TOTAL ASSETS: | 72,381 | 80,701 | 86,671 | 95,321 | 108,682 | 112,801 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4,003 | 3,368 | 3,352 | 3,655 | 3,243 | 3,341 | |||
| Accounts payable | 2,176 | 1,863 | 2,028 | 1,482 | 1,416 | 1,712 | |||
| Accrued liabilities | 1,826 | 1,505 | 1,325 | 2,173 | 1,827 | 1,629 | |||
| Deferred revenue | 60 | 221 | 306 | 362 | 349 | 258 | |||
| Other undisclosed current liabilities | 1,735 | 1,716 | 1,611 | 1,730 | 1,505 | 1,517 | |||
| Total current liabilities: | 5,798 | 5,305 | 5,270 | 5,748 | 5,098 | 5,116 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 1,472 | 1,704 | 1,931 | 2,152 | 3,445 | 3,793 | |||
| Operating lease, liability | 1,472 | 1,704 | 1,931 | 2,152 | 2,250 | 2,458 | |||
| Business combination, contingent consideration, liability | 1,195 | 1,335 | |||||||
| Other undisclosed noncurrent liabilities | 1,327 | 1,295 | 1,118 | 1,407 | 649 | 460 | |||
| Total noncurrent liabilities: | 2,799 | 2,998 | 3,049 | 3,559 | 4,094 | 4,253 | |||
| Total liabilities: | 8,597 | 8,304 | 8,318 | 9,307 | 9,192 | 9,369 | |||
| Equity | |||||||||
| Equity, attributable to parent | 63,784 | 72,398 | 78,353 | 86,014 | 99,490 | 103,432 | |||
| Common stock | 37 | 37 | 36 | 36 | 35 | 35 | |||
| Treasury stock, value | (15,576) | (15,576) | (15,576) | (15,576) | (15,416) | (15,250) | |||
| Additional paid in capital | 100,924 | 99,879 | 98,380 | 96,808 | 94,983 | 92,811 | |||
| Accumulated other comprehensive income | 408 | 371 | 227 | 147 | 613 | 579 | |||
| Retained earnings (accumulated deficit) | (22,010) | (12,313) | (4,714) | 4,598 | 19,275 | 25,257 | |||
| Total equity: | 63,784 | 72,398 | 78,353 | 86,014 | 99,490 | 103,432 | |||
| TOTAL LIABILITIES AND EQUITY: | 72,381 | 80,701 | 86,671 | 95,321 | 108,682 | 112,801 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 641 | 2,657 | 468 | 3,555 | 2,457 | 411 | ||
| Realized investment gains | 293 | 74 | 228 | 988 | 425 | 411 | ||
| Cost of revenue | (297) | (212) | (235) | (2,968) | (256) | (459) | ||
| Cost of product and service sold | (49) | |||||||
| Other undisclosed gross profit | (213) | |||||||
| Gross profit: | 344 | 2,445 | 233 | 587 | 2,201 | (261) | ||
| Operating expenses | (10,579) | (10,125) | (10,493) | (12,413) | (11,137) | (11,733) | ||
| Operating loss: | (10,235) | (7,680) | (10,259) | (11,825) | (8,936) | (11,994) | ||
| Nonoperating income | 561 | 101 | 970 | 983 | 840 | 837 | ||
| Loss from continuing operations before income taxes: | (9,674) | (7,579) | (9,289) | (10,842) | (8,096) | (11,157) | ||
| Income tax expense (benefit) | (22) | (21) | (23) | (3,834) | 2,114 | 2,238 | ||
| Net loss available to common stockholders, diluted: | (9,696) | (7,599) | (9,312) | (14,676) | (5,982) | (8,919) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (9,696) | (7,599) | (9,312) | (14,676) | (5,982) | (8,919) | ||
| Other comprehensive income (loss) | 37 | 145 | 80 | (466) | 34 | 107 | ||
| Comprehensive loss, net of tax, attributable to parent: | (9,659) | (7,455) | (9,232) | (15,142) | (5,949) | (8,811) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.